Tag: hepatocellular carcinoma
Interim findings for SIR-Spheres resin microspheres in unresectable HCC strengthen radioembolization’s...
This advertorial is sponsored by Sirtex Medical.
Although early, findings from the DOORwaY90 trial have prompted discussion on both sides of the Atlantic regarding the...
DOORwaY90 study signals strong efficacy and safety for SIR-Spheres in unresectable...
This advertorial is sponsored by Sirtex Medical.
Interim data from the DOORwaY90 study, a prospective, multicentre, open-label, single-arm trial evaluating SIR-Spheres yttrium-90 (Y-90) resin microspheres...
Efficacy and flexibility of SIRT with SIRSpheres® for treatment of HCC...
This advertorial is sponsored by Sirtex Medical.
Highlights:
This four-page supplement shares insights given by key opinion leaders in selective internal radiation therapy (SIRT) using SIR-Spheres...
Laura Crocetti
“I think the future success of ablation was truly unforeseeable, in 1986, when Tito Livraghi published his first paper about ethanol injection in a...
Call for IRs to standardise reporting of procedures to aid HCC...
The lessons learned from a recent research article were outlined in a presentation by interventional radiologist Maxime Ronot (Beaujon University Hospital, Paris, France) at...
Retrospective review suggests microwave ablation of HCC in the elderly is...
Treating hepatocellular carcinoma (HCC) with microwave ablation is safe in the elderly population, the first study investigating the efficacy and safety profile of this...
CT-guided radiofrequency thermal ablation a safe alternative to surgery for HCC...
Percutaneous CT-guided radiofrequency thermal ablation is a safe and effective alternative treatment option in patients with pulmonary metastases from hepatocellular carcinoma (HCC) that cannot...
New data demonstrate clinical experience with LifePearl microspheres in over 300...
Transarterial chemoembolization (TACE) using LifePearl (Terumo) drug-eluting embolic agents in the treatment of hepatocellular carcinoma has just been published.
International survey reveals high variability in TACE technique
Transarterial chemoembolization (TACE) is a mainstay of locoregional treatment for hepatocellular carcinoma (HCC) in the intermediate stage. “The technique for this procedure, however, continues...
Guerbet announces Lausanne partnership to evaluate immunogenic potential of cTACE
Guerbet has announced a partnership with the Department of Radiodiagnosis and Interventional Radiology of Lausanne's University Hospital (CHUV) and the Lausanne Center for Experimental...
MIRACLE I demonstrates high tumour control rate for drug-eluting microspheres
Goetz Richter, Clinic for Diagnostic and Interventional Radiology, Stuttgart, Germany, presented breaking data from the Miracle 1 multicentre hepatocellular carcinoma trial at The Symposium...
